CALCIMEDICA INC (CALC) Stock Earnings & Estimates
USA - NASDAQ:CALC - US38942Q2021 - Common Stock
3.08 USD
+0.07 (+2.33%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | -28.39M | -37.2M -31.03% | -29.43M 20.89% | -35.43M -20.39% | -32.88M 7.20% | -38.017M -15.62% | -24.146M 36.49% | N/A -23.77% | N/A -22.53% | N/A 1.67% | |
| EBIT YoY % growth | -28.57M | -37.5M -31.26% | -29.83M 20.45% | -35.95M -20.52% | -33.22M 7.59% | -38.075M -14.61% | -24.204M 36.43% | N/A -15.89% | N/A -23.52% | N/A -21.30% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -7.02 87.66% | N/A 74.57% | -25.59 -1,333.61% | -1.23 95.19% | N/A -29.99% | N/A -0.80% | N/A -31.43% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.42 15.85% | -0.39 -2.00% | -0.52 -44.50% | -0.55 -37.70% | -0.56 -33.33% | -0.55 -42.11% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | -7.548M -32.61% | -8.976M -46.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.834M -19.14% | -6.987M -13.20% | -7.956M -22.46% | -8.466M -25.13% | -8.67M -26.87% | -8.67M -24.09% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.40 -11.11% | -0.36 | -0.04 | -12.04% |
| Q1 2025 Q2Q % growth | -0.36 -3,700.00% | -0.31 | -0.05 | -15.09% |
| Q4 2024 Q2Q % growth | -0.38 -65.22% | -0.36 | -0.02 | -5.69% |
| Q3 2024 Q2Q % growth | -0.50 39.02% | -0.51 | 0.01 | 1.30% |
| Q2 2024 Q2Q % growth | -0.36 67.57% | -0.54 | 0.18 | 32.99% |
| Q1 2024 Q2Q % growth | 0.01 100.04% | -0.68 | 0.69 | 101.47% |
| Q4 2023 Q2Q % growth | -0.23 49.89% | -0.89 | 0.66 | 74.16% |
| Q3 2023 Q2Q % growth | -0.82 87.27% | -1.16 | 0.34 | 29.48% |
| Q2 2023 Q2Q % growth | -1.11 79.14% | -1.07 | -0.04 | -4.14% |
| Q1 2023 Q2Q % growth | -23.43 -248.66% | -0.74 | -22.69 | -3,046.66% |
| Q4 2022 Q2Q % growth | 92.00% | -0.46 | % | |
| Q3 2022 Q2Q % growth | -6.44 -1,594.74% | -6.28 | -0.16 | -2.50% |
| Q2 2022 Q2Q % growth | -5.32 -1,377.78% | -5.74 | 0.42 | 7.33% |
| Q1 2022 Q2Q % growth | -6.72 -1,144.44% | -5.46 | -1.26 | -23.06% |
| Q4 2021 Q2Q % growth | -5.74 -315.94% | -5.23 | -0.51 | -9.83% |
| Q3 2021 Q2Q % growth | -0.38 84.92% | -0.38 | 0.00 | -0.69% |
| Q2 2021 Q2Q % growth | -0.36 | -0.48 | 0.12 | 24.59% |
| Q1 2021 Q2Q % growth | -0.54 | -0.45 | -0.09 | -20.32% |
| Q4 2020 Q2Q % growth | -1.38 | -0.41 | -0.97 | -234.06% |
| Q3 2020 Q2Q % growth | -2.52 | -0.57 | -1.95 | -341.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 76.5K | -76.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.25% | 0% | -1.79% |
| Revenue | N/A | N/A | N/A | N/A |